Phase I Study of Fluvastatin-Celebrex Association for Optico-chiasmatic Low Grade Gliomas and High Grade Gliomas Localized Outside the Brainstem, Relapsed or Refactory, in Children or Young Adults
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2019
Price : $35 *
At a glance
- Drugs Celecoxib (Primary) ; Fluvastatin
- Indications Glioma
- Focus Adverse reactions
- Acronyms FLUVABREX
- 28 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Jun 2018 Planned number of patients changed from 35 to 21.
- 27 Jun 2018 Planned End Date changed from 1 Oct 2020 to 1 Oct 2022.